| 000 | 01905 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514073738.0 | ||
| 264 | 0 | _c20030826 | |
| 008 | 200308s 0 0 eng d | ||
| 022 | _a0019-9567 | ||
| 024 | 7 |
_a10.1128/IAI.71.8.4238-4249.2003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUehori, Junji | |
| 245 | 0 | 0 |
_aSimultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan. _h[electronic resource] |
| 260 |
_bInfection and immunity _cAug 2003 |
||
| 300 |
_a4238-49 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Wall _xchemistry |
| 650 | 0 | 4 |
_aDendritic Cells _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMycobacterium bovis _xchemistry |
| 650 | 0 | 4 |
_aPeptidoglycan _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xantagonists & inhibitors |
| 650 | 0 | 4 | _aToll-Like Receptor 1 |
| 650 | 0 | 4 | _aToll-Like Receptor 10 |
| 650 | 0 | 4 | _aToll-Like Receptor 2 |
| 650 | 0 | 4 | _aToll-Like Receptor 4 |
| 650 | 0 | 4 | _aToll-Like Receptors |
| 700 | 1 | _aMatsumoto, Misako | |
| 700 | 1 | _aTsuji, Shoutaro | |
| 700 | 1 | _aAkazawa, Takashi | |
| 700 | 1 | _aTakeuchi, Osamu | |
| 700 | 1 | _aAkira, Shizuo | |
| 700 | 1 | _aKawata, Tsutomu | |
| 700 | 1 | _aAzuma, Ichiro | |
| 700 | 1 | _aToyoshima, Kumao | |
| 700 | 1 | _aSeya, Tsukasa | |
| 773 | 0 |
_tInfection and immunity _gvol. 71 _gno. 8 _gp. 4238-49 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/IAI.71.8.4238-4249.2003 _zAvailable from publisher's website |
| 999 |
_c12651726 _d12651726 |
||